Ikarian Capital, LLC Agios Pharmaceuticals, Inc. Call Options Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $6.51 Million - $7.66 Million	-125,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$33.21 - $46.54 $4.15 Million - $5.82 Million	125,000 New	125,000 $5.42 Million
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $1.58 Million - $2.69 Million	-50,000 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$30.08 - $50.59 $1.5 Million - $2.53 Million	50,000 New	50,000 $2.39 Million

243

58.3M

431K

309K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.82B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.